Q2 2013

Filed Aug 19, 2013 · 10-Q · 50 days after period end · 0001354488-13-004782

Q2 2013 · 10-Q

Revenue—

Net Income

-$303.04K

N/M vs Q2 2012

EPS Diluted

$0.00

— vs Q2 2012

Operating Income-$285,599N/M

Operating Cash Flowderived-$141,025N/M

Same quarter

Metric	Q2 2013	Q2 2012	Q2 2011	Q2 2010
Revenue	—	$0.00	$0.00	$0.00
Net Income	-$303.04K	-$513.81K	-$335.71K	-$181.07K
EPS Diluted	$0.00	$0.00	$0.00	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR